Karma Biotechnologies Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
Karma Biotechnologies General Information
Description
Developer of drug therapeutics intended to elicit antigen-specific immune tolerance in vivo. The company leverages immunology and lipid nanoparticle engineering to develop off-the-shelf therapeutics to suppress the rogue immune responses that cause autoimmunity, allergies and food sensitivities, enabling pharmaceutical businesses to expand their allergy pipelines in competing markets.
Contact Information
Website
www.karmabiotech.comCorporate Office
- 370 Amapola Avenue
- Suite 101
- Torrance, CA 90501
- United States
Corporate Office
- 370 Amapola Avenue
- Suite 101
- Torrance, CA 90501
- United States
Karma Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 25-Jul-2025 | Completed | Out of Business | |||
| 6. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 5. Seed Round | 21-May-2023 | Completed | Generating Revenue | |||
| 4. Seed Round | 21-Oct-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 03-Sep-2019 | Completed | Generating Revenue | |||
| 2. Seed Round | 15-Aug-2019 | $50K | $100K | Completed | Generating Revenue | |
| 1. Seed Round | 24-Apr-2017 | $50K | $50K | Completed | Startup |
Karma Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 605,326 | $0.000100 | $0.01 | $0.08 | $0.08 | $0.08 | 3.1% | |
| Seed-1 | 3,926,187 | $0.000100 | $0.04 | $0.51 | $0.51 | $0.51 | 20.14% |
Karma Biotechnologies Comparisons
Industry
Financing
Details
Karma Biotechnologies Competitors (2)
One of Karma Biotechnologies’s 2 competitors is Parvus Therapeutics, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Parvus Therapeutics | Venture Capital-Backed | South San Francisco, CA | ||||
| Selecta Biosciences | Formerly VC-backed | Watertown, MA |
Karma Biotechnologies Patents
Karma Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4463138-A1 | Multi-vesicular lipid nanoparticle tolerogenic vaccines for induction of systemic immune tolerance in vivo | Pending | 14-Jan-2022 | ||
| US-20250064740-A1 | Multi-vesicular lipid nanoparticle tolerogenic vaccines for induction of systemic immune tolerance in vivo | Pending | 14-Jan-2022 | ||
| WO-2023137227-A1 | Multi-vesicular lipid nanoparticle tolerogenic vaccines for induction of systemic immune tolerance in vivo | Inactive | 14-Jan-2022 | ||
| WO-2023137227-A9 | Multi-vesicular lipid nanoparticle tolerogenic vaccines for induction of systemic immune tolerance in vivo | Inactive | 14-Jan-2022 | ||
| EP-3784216-A1 | Multi-vesicular liposomes for targeted delivery of drugs and biologics for tissue engineering | Pending | 27-Apr-2018 | A61K31/337 |
Karma Biotechnologies Signals
Karma Biotechnologies FAQs
-
When was Karma Biotechnologies founded?
Karma Biotechnologies was founded in 2017.
-
Where is Karma Biotechnologies headquartered?
Karma Biotechnologies is headquartered in Torrance, CA.
-
What is the size of Karma Biotechnologies?
Karma Biotechnologies has 3 total employees.
-
What industry is Karma Biotechnologies in?
Karma Biotechnologies’s primary industry is Drug Discovery.
-
Is Karma Biotechnologies a private or public company?
Karma Biotechnologies is a Private company.
-
What is Karma Biotechnologies’s current revenue?
The current revenue for Karma Biotechnologies is .
-
How much funding has Karma Biotechnologies raised over time?
Karma Biotechnologies has raised $4.98M.
-
Who are Karma Biotechnologies’s competitors?
Parvus Therapeutics and Selecta Biosciences are competitors of Karma Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process